On July 30, 2026, a federal judge in Indiana sentenced the owner of one of the internet's best-known peptide vendors to 70 months in prison. The case is worth understanding in detail, because the specific thing he was convicted of is the specific thing this site tells you to check.
- Matthew Kawa, 48, who ran Paradigm Peptides, was sentenced to 70 months and agreed to forfeit $5 million
- He admitted to forging laboratory certificates — the documents customers used to verify purity
- Products were advertised as made in America and 99% pure; they were imported from China, India, and elsewhere
- Six compounds sold as testosterone-mimicking SARMs actually contained testosterone
- 54,000 customers across all 50 states and 80 countries
Quick facts
- Sentenced
- July 30, 2026
- Defendant
- Matthew Kawa, 48, of Grant Park, Illinois
- Sentence
- 70 months, plus 1 year supervised release
- Forfeiture
- $5 million
- Company
- Paradigm Peptides (shut down March 2024)
- Court
- N.D. Indiana, Judge Cristal Brisco
What he was actually convicted of
Kawa pleaded guilty to introducing unapproved drugs into interstate commerce with intent to defraud and mislead, and to illegally importing merchandise into the United States.[1] His sister, Jennifer Stechkober, 32, was sentenced to 16 months after pleading guilty in the same case.
Paradigm Peptides operated the way a great many peptide vendors still operate. It advertised its products as manufactured in America, of 99% purity, and verified by third-party laboratories — and it attached the familiar disclaimer that everything was sold for research use only. Court filings establish that the products were imported from China, India, and other countries.[2]
The purity documentation was forged. Kawa admitted to fabricating laboratory certificates to make the products look independently verified.[1]
Sentencing him, U.S. District Court Judge Cristal Brisco said: "You focused on what you wanted to build instead of thinking about the people."[2]
The part that should worry customers most
Testing found that six compounds sold as SARMs — selective androgen receptor modulators, a class of research chemicals distinct from peptides — all contained actual testosterone.[2]
Sit with what that means for the person who bought them. They believed they were taking a non-hormonal compound. They were in fact taking an anabolic steroid, at an unknown dose, with no label warning them. Anyone who had a reason to avoid testosterone — a hormone-sensitive condition, a pregnancy, a competitive drug test, a course of treatment their doctor was managing — had no way to know. Nothing on the product, and nothing in the paperwork, would have told them.
That is the difference between a product that is unproven and a product that is not what it says it is. Most of this site is about the first problem. This case is about the second.
Why "research use only" did not protect anyone
The phrase "for research use only" is doing a lot of work on peptide vendor sites, and it is worth being clear about what it does and does not do.
It is not a regulatory category that makes a sale lawful. It does not mean a regulator has reviewed the product. It does not mean the contents match the label. In this prosecution it functioned as exactly what it appears to be — a disclaimer attached to consumer sales of unapproved drugs — and it did not prevent a conviction for introducing unapproved drugs into interstate commerce.
If you are buying something you intend to put in your body, the label saying it is not for that purpose is not a safety feature. It is a liability shield for the seller.
What a forged COA means for the advice everyone gives
The standard advice — including ours — is to ask for a certificate of analysis. That advice is still right. But this case shows its limit, and we would rather say so than pretend otherwise.
A COA is a document. Documents can be fabricated. Paradigm's customers, for years, were looking at paperwork that appeared to confirm 99% purity and third-party testing, and the paperwork was fiction.
What still works is verification that does not depend on the seller's honesty:
- Go to the laboratory, not the seller. A COA names an issuing lab and usually a report number. Contact the lab directly and confirm the report exists. A real lab will tell you. A forged certificate typically names a real lab that never issued it.
- Treat a PDF from the vendor's own site as unverified. It is a marketing asset until an independent party confirms it.
- Be sceptical of round, flattering numbers. "99% purity" across an entire catalogue is a claim about a manufacturing process that few sellers control, particularly when the product is imported.
- Ask where it was actually made. "Made in America" was a central misrepresentation here, and it is an easy claim to make and a hard one for a customer to check.
Our guide to verifying a certificate of analysis walks through this in detail, and our guide to evaluating a peptide clinic covers the same problem where a provider is involved.
The wider picture
This is the first major criminal sentencing of a research-use-only peptide seller, and it lands in a period of broader enforcement. Paradigm shut down in March 2024; Peptide Sciences closed in March 2026; and FDA enforcement against gray-market sellers has continued through 2026.
It is worth separating two things that often get blurred together. The peptides themselves — whether BPC-157 does anything for a tendon, whether MOTS-c does anything in humans — are an evidence question, and on most of them the honest answer is that we do not know yet. Whether the vial in front of you contains what the label says is a completely different question, and it is one where the track record of the unregulated market is now a matter of federal court record.
You can hold both thoughts at once: the science is genuinely interesting, and the supply chain selling it to you has been, in documented cases, fraudulent.
References
- [1]U.S. Department of Justice, U.S. Attorney's Office, Northern District of Indiana. “Illinois Man and Indiana Woman Sentenced Respectively to 70 Months and 16 Months in Prison For Selling Unapproved Drugs in Interstate Commerce.” 2026. Link
Primary source: DOJ press release announcing the July 30, 2026 sentencing. Documents the charges, sentences, and $5 million forfeiture.
- [2]CBS News. “Judge sentences peptide vendor to nearly 6 years in prison for 'an incredible trail of harm'.” 2026. Link
Contemporaneous court reporting from the sentencing hearing, including the judge's remarks and the laboratory testing findings on the SARM products.
- [3]U.S. Department of Justice. “United States v. Matthew Kawa — case page.” 2026. Link
DOJ case landing page for the prosecution.
Stay informed
Get evidence-based peptide updates. No spam, no vendor pitches — just the research and regulatory changes that matter.
Related content
How to Verify a Certificate of Analysis
The checks that do not depend on trusting the seller — including confirming a report directly with the issuing laboratory.
NewsWhat Happened to Peptide Sciences
The 2026 closure of one of the largest gray-market peptide vendors, and what it signalled.
NewsFDA Enforcement and the Gray Market
A timeline of enforcement actions against unregistered peptide sellers.
GuideHow to Evaluate a Peptide Clinic
A scorecard for assessing providers, with the red flags that matter most.